Skip to main content
Top
Published in: International Cancer Conference Journal 3/2018

Open Access 01-07-2018 | Case report

Pyoderma gangrenosum after radical prostatectomy: case report

Authors: Akiyoshi Osaka, Hisamitsu Ide, Shinichi Ban, Toshiro Takimoto, Keiichiro Aoki, Yoshitomo Kobori, Tadahiko Tokumoto, Gaku Arai, Shigehiro Soh, Yoshihiko Ueda, Hiroshi Okada

Published in: International Cancer Conference Journal | Issue 3/2018

Login to get access

Abstract

Pyoderma gangrenosum (PG) is a skin disease characterized by an unknown neutrophilic infiltration in dermis and a nonbacterial destructive ulcer. Post-operative PG is an extremely rare type that occurs around surgical sites during the immediate post-operative period. It is usually diagnosed as surgical site infection at the time of presentation. The condition rapidly worsens despite antibiotic treatment and debridement. We report on a case of post-operative PG in a 64-year-old man after radical prostatectomy. Following the operation, redness and pus from surgical site rapidly progress although repeated antibiotic therapy and debridement were performed. Although the patient received appropriate debridement and broad-spectrum antibiotic treatment, the ulcerative lesion spread surrounding drain region and the condition of the skin region deteriorated. The diagnosis of PG was made by a skin biopsy that presented only neutrophilic invasion in the dermis without vasculitis, tumor, or malignancy. Finally, the patient died of lesion progression in whole body and multiple organ dysfunction. Considering PG along with ulcers, wounds, and post-operative complications is critical for prompt diagnosis and proper treatment.
Literature
1.
go back to reference Powell FC, Su WP, Perry HO (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34(3):395–409CrossRefPubMed Powell FC, Su WP, Perry HO (1996) Pyoderma gangrenosum: classification and management. J Am Acad Dermatol 34(3):395–409CrossRefPubMed
2.
go back to reference Tolkachjov SN, Fahy AS, Wetter DA et al (2015) Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. J Am Acad Dermatol 73(4):615–622CrossRefPubMed Tolkachjov SN, Fahy AS, Wetter DA et al (2015) Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014. J Am Acad Dermatol 73(4):615–622CrossRefPubMed
3.
go back to reference Zuo KJ, Fung E, Tredget EE et al (2015) A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management strategy. J Plast Reconstr Aesthet Surg 68:295–303CrossRefPubMed Zuo KJ, Fung E, Tredget EE et al (2015) A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management strategy. J Plast Reconstr Aesthet Surg 68:295–303CrossRefPubMed
4.
go back to reference Tolkachjov SN, Fahy AS, Cerci FB et al (2016) Postoperative pyoderma gangrenosum: a clinical review of published cases. Mayo Clin Proc 91(9):1267–1279CrossRefPubMed Tolkachjov SN, Fahy AS, Cerci FB et al (2016) Postoperative pyoderma gangrenosum: a clinical review of published cases. Mayo Clin Proc 91(9):1267–1279CrossRefPubMed
5.
go back to reference Brunsting LA, Goeckerman WH, O’Leary PA (1930) Pyoderma (ecthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Derm Syphilol 22(4):655–680CrossRef Brunsting LA, Goeckerman WH, O’Leary PA (1930) Pyoderma (ecthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Derm Syphilol 22(4):655–680CrossRef
6.
go back to reference Dolan OM, Burrows D, Walsh M (1997) Pyoderma gangrenosum of the breast treated with low-dose cyclosporine A. Clin Exp Dermatol 22(2):92–95CrossRefPubMed Dolan OM, Burrows D, Walsh M (1997) Pyoderma gangrenosum of the breast treated with low-dose cyclosporine A. Clin Exp Dermatol 22(2):92–95CrossRefPubMed
7.
go back to reference Davis MD, Alexander JL, Prawer SE (2006) Pyoderma gangrenosum of the breasts precipitated by breast surgery. J Am Acad Dermatol 55(2):317–320CrossRefPubMed Davis MD, Alexander JL, Prawer SE (2006) Pyoderma gangrenosum of the breasts precipitated by breast surgery. J Am Acad Dermatol 55(2):317–320CrossRefPubMed
8.
go back to reference Wang JY, French LE, Shear NH, Amiri A, Alavi A (2018) Drug-induced pyoderma gangrenosum: a review. Am J Clin Dermatol 19(1):67–77CrossRefPubMed Wang JY, French LE, Shear NH, Amiri A, Alavi A (2018) Drug-induced pyoderma gangrenosum: a review. Am J Clin Dermatol 19(1):67–77CrossRefPubMed
9.
go back to reference Malech HL, Gallin JI (1987) Current concepts: immunology. Neutrophils in human diseases. N Engl J Med 317(11):687–694CrossRefPubMed Malech HL, Gallin JI (1987) Current concepts: immunology. Neutrophils in human diseases. N Engl J Med 317(11):687–694CrossRefPubMed
10.
go back to reference Adachi Y, Kindzelskii AL, Cookingham G et al (1998) Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol 111(2):259–268CrossRefPubMed Adachi Y, Kindzelskii AL, Cookingham G et al (1998) Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol 111(2):259–268CrossRefPubMed
11.
go back to reference Oka M, Berking C, Nesbit M et al (2000) Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest 80(4):595–604CrossRefPubMed Oka M, Berking C, Nesbit M et al (2000) Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts. Lab Invest 80(4):595–604CrossRefPubMed
12.
go back to reference Binus AM, Qureshi AA, Li WW et al (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165(6):1244–1250CrossRefPubMed Binus AM, Qureshi AA, Li WW et al (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165(6):1244–1250CrossRefPubMed
13.
go back to reference Langan SM, Groves RW, Card TR et al (2012) Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 132(9):2166–2170CrossRefPubMed Langan SM, Groves RW, Card TR et al (2012) Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 132(9):2166–2170CrossRefPubMed
14.
go back to reference Su WP, Davis MD, Roger H et al (2004) Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 43(11):790–800CrossRefPubMed Su WP, Davis MD, Roger H et al (2004) Pyoderma gangrenosum: clinicopathologic correlation and proposed diagnostic criteria. Int J Dermatol 43(11):790–800CrossRefPubMed
15.
go back to reference Brown TS, Marshall GS, Callen JP (2000) Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol 43(1):108–112CrossRefPubMed Brown TS, Marshall GS, Callen JP (2000) Cavitating pulmonary infiltrate in an adolescent with pyoderma gangrenosum: a rarely recognized extracutaneous manifestation of a neutrophilic dermatosis. J Am Acad Dermatol 43(1):108–112CrossRefPubMed
16.
go back to reference Ye MJ, Ye JM (2014) Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol Res Pract 2014:461–467CrossRef Ye MJ, Ye JM (2014) Pyoderma gangrenosum: a review of clinical features and outcomes of 23 cases requiring inpatient management. Dermatol Res Pract 2014:461–467CrossRef
Metadata
Title
Pyoderma gangrenosum after radical prostatectomy: case report
Authors
Akiyoshi Osaka
Hisamitsu Ide
Shinichi Ban
Toshiro Takimoto
Keiichiro Aoki
Yoshitomo Kobori
Tadahiko Tokumoto
Gaku Arai
Shigehiro Soh
Yoshihiko Ueda
Hiroshi Okada
Publication date
01-07-2018
Publisher
Springer Japan
Published in
International Cancer Conference Journal / Issue 3/2018
Electronic ISSN: 2192-3183
DOI
https://doi.org/10.1007/s13691-018-0332-3

Other articles of this Issue 3/2018

International Cancer Conference Journal 3/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine